ConductScience.org, home

Paper464572

Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole.

Grose WE and 2 others. Antimicrob Agents Chemother, 1979. Cited by 59 papers, by iCite.

Cite this record

ConductScience Library. Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole. Papers, record 464572. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/464572

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
3.29
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grose WEW E
2Bodey GPG P
3Loo TLT L

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SulfamethoxazoleMajor topic
TrimethoprimMajor topic
Adolescent
Adult
Aged
Bacterial Infections
Drug Combinations
Female
Humans
Injections, Intravenous
Kinetics
Male
Middle Aged
Time Factors

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1576166Sulfamethoxazole-trimethoprim for infections in cancer patients.JAMA1977https://conductscience.org/library/papers/576166PubMed
25985268Potentiation of sulfonamides and antibiotics by trimethoprim [2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine].Antimicrob Agents Chemother (Bethesda)1966https://conductscience.org/library/papers/5985268PubMed
34148416Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.J Infect Dis1973https://conductscience.org/library/papers/4148416PubMed
44585960Trimethoprim-sulfamethoxazole: absorption, excretion, and toxicity in six children.J Infect Dis1973https://conductscience.org/library/papers/4585960PubMed
54585959Trimethoprim-sulfamethoxazole in children: pharmacokinetics and clinical studies.J Infect Dis1973https://conductscience.org/library/papers/4585959PubMed
64585951Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.J Infect Dis1973https://conductscience.org/library/papers/4585951PubMed
74580950Trimethoprim in human saliva, bronchial secretion and lung tissue.Acta Pharmacol Toxicol (Copenh)1973https://conductscience.org/library/papers/4580950PubMed
84758050
Absorption and urinary execretion of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole: results with single doses in normal young adults and preliminary observations during therapy with trimethoprim-sulfamethoxazole.
J Infect Dis1973https://conductscience.org/library/papers/4758050PubMed
94758048Excretion of sulfamethoxazole and trimethoprim into human bile.J Infect Dis1973https://conductscience.org/library/papers/4758048PubMed
104758046Pharmacokinetics of trimethoprim and sulfamethoxazole in normal subjects and in patients with renal failure.J Infect Dis1973https://conductscience.org/library/papers/4758046PubMed
114758045Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man.J Infect Dis1973https://conductscience.org/library/papers/4758045PubMed
124901344Single-blind comparative trial of trimethoprim-sulphamethoxazole and ampicillin in the treatment of exacerbations of chronic bronchitis.Br Med J1969https://conductscience.org/library/papers/4901344PubMed
135301731Trimethoprim, a sulphonamide potentiator.Br J Pharmacol Chemother1968https://conductscience.org/library/papers/5301731PubMed
141039907Pharmacokinetics and efficacy of trimethoprim-sulfamethoxazole in the treatment of gastroenteritis in children.Can Med Assoc J1975https://conductscience.org/library/papers/1039907PubMed
155514974Pharmacokinetics of sulfamethoxazole plus trimethoprim in man and their distribution in the rat.Chemotherapy1970https://conductscience.org/library/papers/5514974PubMed
165361314Species differences among dihydrofolate reductases as a basis for chemotherapy.Postgrad Med J1969https://conductscience.org/library/papers/5361314PubMed
175379870Spectrofluorimetric method for the determination of trimethoprim in body fluids.Chemotherapy1969https://conductscience.org/library/papers/5379870PubMed

Download CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
39148353Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy.Clin Pharmacol Ther2025https://conductscience.org/library/papers/39148353PubMed
38681899Lessons from Multiple Infections Such as Lymphoma Complicated with Pneumocystis Infection: A Case Report.Infect Drug Resist2024https://conductscience.org/library/papers/38681899PubMed
34570646Uropathogenic Escherichia coli Shows Antibiotic Tolerance and Growth Heterogeneity in an In Vitro Model of Intracellular Infection.Antimicrob Agents Chemother2021https://conductscience.org/library/papers/34570646PubMed
34011959A trimethoprim derivative impedes antibiotic resistance evolution.Nat Commun2021https://conductscience.org/library/papers/34011959PubMed
32571820Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/32571820PubMed
24910807Cotrimoxazole - optimal dosing in the critically ill.Ann Intensive Care2014https://conductscience.org/library/papers/24910807PubMed
15227389Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions.Tex Heart Inst J1990https://conductscience.org/library/papers/15227389PubMed
8504623Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia.Clin Pharmacokinet1993https://conductscience.org/library/papers/8504623PubMed
7786002
Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.
Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7786002PubMed
7408366Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).Clin Pharmacokinet1980https://conductscience.org/library/papers/7408366PubMed
7387137Evaluation of slow infusions of co-trimoxazole by using predictive pharmacokinetics.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7387137PubMed
7025751Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7025751PubMed
6973756Poor rectal absorption of trimethoprim/sulphamethoxazole in treating Pneumocystis carinii pneumonia.Postgrad Med J1981https://conductscience.org/library/papers/6973756PubMed
6759092Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.Drugs1982https://conductscience.org/library/papers/6759092PubMed
6335381Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6335381PubMed
6332015Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.Eur J Clin Microbiol1984https://conductscience.org/library/papers/6332015PubMed
3920958Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3920958PubMed
3052984Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.Clin Pharmacokinet1988https://conductscience.org/library/papers/3052984PubMed
2126691Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2126691PubMed
525997Rapid assay for determination of trimethoprim and sulfamethoxazole levels in serum by spectrofluorometry.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/525997PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/464572

GET https://conductscience.org/api/papers/v1/464572/authors